![Industry Viewpoints: Investigator-Initiated Studies – A Challenge for Supply with IMPs? - Clinical Trials Arena Industry Viewpoints: Investigator-Initiated Studies – A Challenge for Supply with IMPs? - Clinical Trials Arena](https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2018/09/shutterstock_194807486.jpg)
Industry Viewpoints: Investigator-Initiated Studies – A Challenge for Supply with IMPs? - Clinical Trials Arena
![Sponsor-Investigators Frequently Cited in FDA Warning Letters. Do You Know What Is Required for a High Quality Trial? — Clinical Pathways Sponsor-Investigators Frequently Cited in FDA Warning Letters. Do You Know What Is Required for a High Quality Trial? — Clinical Pathways](https://images.squarespace-cdn.com/content/v1/55343e1fe4b0c39656d4ba43/1629210921579-7QR1TK8E0CH5S9UPG88I/IIT+Pic.png)
Sponsor-Investigators Frequently Cited in FDA Warning Letters. Do You Know What Is Required for a High Quality Trial? — Clinical Pathways
![A meta-research study revealed several challenges in obtaining placebos for investigator-initiated drug trials - ScienceDirect A meta-research study revealed several challenges in obtaining placebos for investigator-initiated drug trials - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0895435620311768-fx1.jpg)
A meta-research study revealed several challenges in obtaining placebos for investigator-initiated drug trials - ScienceDirect
Investigator Initiated Trials (IIT) – Considerations and Guidance from the Perspective of Clinical Trial Supplies and GMP | ISPE | International Society for Pharmaceutical Engineering
![Guide for Investigator Initiated Trials: 9783805596848: Medicine & Health Science Books @ Amazon.com Guide for Investigator Initiated Trials: 9783805596848: Medicine & Health Science Books @ Amazon.com](https://m.media-amazon.com/images/I/51z8HOypqkL._AC_UF1000,1000_QL80_.jpg)
Guide for Investigator Initiated Trials: 9783805596848: Medicine & Health Science Books @ Amazon.com
![Investigator-initiated trials of targeted oncology agents: why independent research is at risk? - Annals of Oncology Investigator-initiated trials of targeted oncology agents: why independent research is at risk? - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/424ca98b-0673-4b87-bef8-067f7daf4b4d/gr1.jpg)
Investigator-initiated trials of targeted oncology agents: why independent research is at risk? - Annals of Oncology
![Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT) | BMC Medical Research Methodology | Full Text Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT) | BMC Medical Research Methodology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12874-021-01359-x/MediaObjects/12874_2021_1359_Fig8_HTML.png)